Source: Jarvis, JP, et al. Real-World Impact of a Pharmacogenomics-Enriched
Comprehensive Medication Management Program. Journal of Personalized Medicine, 2022
Medication Therapy Management (MTM)
Drives “adherence”
to standardized clinical pathways
to reimbursement protocols
to formulary guidelines
to “typical” medication regimens
VS
Medication Therapy Optimization (MTO)
Drives efficacy & safety
for individual patients
informed by the most current medical & data science
The DecisionRx MTO Platform
Our specialized clinical pharmacists act as unbiased patient advocates to optimize each member’s medication therapy for efficacy, safety, adherence, and total healthcare cost.
The DecisionRx MTO platform incorporates:
Proprietary medication risk stratification
Clinical history and medical claims analysis
Pharmacogenomics testing
Comprehensive medication review by specialized clinical pharmacists
Coordination with prescribers’ existing workflows
A value-based economic model: DecisionRx bears the full cost of MTO implementation
The MTO process enables physicians to optimize and tailor medication plans for each patient, improving outcomes and reducing healthcare costs. The platform focuses on buying the right drugs, rather than merely buying drugs at the right price.
The DecisionRx platform assigns medication failure risk scores to each patient using the most current clinical data regarding drug interactions, contraindications, side effects, adverse events, FDA warnings, and pharmacogenomics. These risk scores prioritize patients most likely to benefit from comprehensive pharmacist reviews, dramatically reducing the clinical and economic costs of non-optimized medication therapy.